Special Issue "Current Evidences and New Therapeutic Frontiers in Malignant Pleural Mesothelioma"
Deadline for manuscript submissions: 30 June 2021.
2. Università Cattolica del Sacro Cuore, Rome, Italy
Interests: pulmonary metastasectomy; malignant pleural mesothelioma; pulmonary laser resection; thymic and pleural tumors; hyperthermic intrathoracic chemotherapy (HITHOC)
As you know, malignant pleural mesothelioma (MPM) is a very rare aggressive cancer affecting an increasing number of people worldwide.
In the last decade, the investigation of its biomolecular mechanisms have led to the definition of different types of mesothelioma on the basis of gene expression, but molecularly defined groups based on prognosis are still far from being defined.
At the same time, regardless of the treatment, long-term survival is extremely poor in MPM patients because no valid therapeutic strategies have been validated.
In particular, surgical resection for MPM is a controversial topic with no universally accepted guidelines. Similarly, the frontiers of oncology are still unexplored, with immunotherapeutic approach showing controversial results in these patients.
This Special Issue the following goals:
(1) To offer to the Readers an overview on the current therapeutic options in MPM;
(2) To analyze the pathological features, genetic profile and biomolecular mechanism of MPM;
(3) To report the new frontiers in the surgical and oncological treatment of MPM.
In this sense, all submissions addressing all of the above highlighted aspects on MPM are welcome to this Special Issue. Thus, original articles, comprehensive reviews, and expert opinions are of the utmost interest, given the expansive scope of this area.
Prof. Dr. Filippo Lococo
Dr. Andrea Billè
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- malignant pleural mesothelioma
- pleurectomy and decortication